Of the 6 unique peptide sequences that were available from the control digest of recombinant SAS1B, 5 SAS1B peptides were identified as perfect matches in the MS/MS spectra of the immunoprecipitate, thereby confirming the presence of SAS1B in the sample recovered from uterine cancer cells (Figure 4C4). This evidence concerns the gene ASTL and uterine cancer.